Shopping Cart
Remove All
Your shopping cart is currently empty
Marstacimab (PF-06741086) is a neutralizing antibody that binds to and inhibits inhibitors of the human tissue factor pathway. Marstacimab is an anti-tissue factor pathway inhibitor used in the study of hemophilia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | In Stock | In Stock | |
| 5 mg | $723 | In Stock | In Stock | |
| 10 mg | $986 | - | In Stock | |
| 25 mg | $1,490 | - | In Stock | |
| 50 mg | $1,970 | - | In Stock |
| Description | Marstacimab (PF-06741086) is a neutralizing antibody that binds to and inhibits inhibitors of the human tissue factor pathway. Marstacimab is an anti-tissue factor pathway inhibitor used in the study of hemophilia. |
| In vitro | Marstacimab was able to reduce corn trypsin (CT) levels in whole blood samples from hemophiliacs at concentrations of 20, 50 and 100 nmol/L. [1] In an in vitro assay, Marstacimab (16 μg/mL) not only shortened the clotting lag time and increased thrombin generation in human non-hemophilic platelet depleted plasma samples, but also increased peak thrombin in hemophilia A and hemophilia B plasma samples. [2] |
| In vivo | In a mouse model of acute hemorrhage, Marstacimab administered intravenously at a dose of 0.5 mg/kg had no hemodynamic effects. [2] |
| Synonyms | PF-6741086, PF6741086, PF-06741086, PF06741086 |
| Cas No. | 1985638-39-8 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.